Article
Genotyping CYP2D6 by three different methods: advantages and disadvantages.
Drug metabolism and personalized therapy - 1 Mar 2017
Ribeiro Carolina, Martins Patrícia, Grazina Manuela
Abstract excerpt
BACKGROUND: CYP2D6 belongs to P450 superfamily, and is responsible for the metabolism of 25% of the drugs used clinically. Genetic variability of CYP2D6 affects individual drug or toxic response leading to differences in the drug outcome or toxicity mediating adverse drug effects. The different variant alleles are associated with increased, decreased, or abolished enzyme hydroxylation functions. The CYP2D6*10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
